Health World Mauritania: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health World Mauritania.

Press releases published on October 26, 2026

Oct. 26, 2026

Novastra Therapeutics Reports Encouraging First Clinical Data for Its Novel XIRT™/OAP Cancer Immune Therapy at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

TransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Years

Indeterminate GlobeNewswire

Oct. 26, 2026

Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline

Indeterminate GlobeNewswire

Oct. 26, 2026

BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshop

Indeterminate GlobeNewswire

Oct. 26, 2026

Amwell® to report third quarter 2026 operating results

Indeterminate GlobeNewswire

Oct. 26, 2026

Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 26, 2026

Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia

Indeterminate GlobeNewswire

Oct. 26, 2026

Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain

Indeterminate GlobeNewswire

Oct. 26, 2026

Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP

Indeterminate GlobeNewswire

Oct. 26, 2026

Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC

Indeterminate GlobeNewswire

Oct. 26, 2026

BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives

Indeterminate GlobeNewswire

Oct. 26, 2026

Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Oct. 26, 2026

MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer

Indeterminate GlobeNewswire

Oct. 26, 2026

Serapha Bio Announces Positive Interim Safety and Efficacy Data from the SERP-01 Investigator-Initiated Trial Presented at the ERS Alpha-1 Antitrypsin Conference 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator

Indeterminate GlobeNewswire

Oct. 26, 2026

Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness

Indeterminate GlobeNewswire

Oct. 26, 2026

Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

TILT Biotherapeutics Presents Encouraging Phase 1b Results in Ovarian Cancer at ESMO 2026

Indeterminate GlobeNewswire